Omega Therapeutics, Inc. - COMMON STOCK (OMGAQ)

CUSIP: 68217N105

Q2 2024 13F Holders as of 30 Jun 2024

Type / Class
Equity / COMMON STOCK
Shares outstanding
55,351,475
Total 13F shares
50,536,326
Share change
-615,473
Total reported value
$104,609,269
Put/Call ratio
91%
Price per share
$2.07
Number of holders
66
Value change
-$2,392,066
Number of buys
29
Number of sells
43

Quarterly Holders Quick Answers

What is CUSIP 68217N105?
CUSIP 68217N105 identifies OMGAQ - Omega Therapeutics, Inc. - COMMON STOCK in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of Omega Therapeutics, Inc. - COMMON STOCK (OMGAQ) as of Q2 2024

As of 30 Jun 2024, Omega Therapeutics, Inc. - COMMON STOCK (OMGAQ) was held by 66 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 50,536,326 shares. The largest 10 holders included Flagship Pioneering Inc., FMR LLC, HarbourVest Partners LLC, STATE OF WISCONSIN INVESTMENT BOARD, Artal Group S.A., VANGUARD GROUP INC, Blue Owl Capital Holdings LP, CITADEL ADVISORS LLC, MILLENNIUM MANAGEMENT LLC, and 683 Capital Management, LLC. This page lists 66 institutional shareholders reporting positions in this security for the Q2 2024 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.